Hepatic fat quantification magnetic resonance for monitoring treatment response in pediatric nonalcoholic steatohepatitis

World Journal of Gastroenterology

Volumn 21, Issue 33, 2015, Pages 9741-9748

  Koh, Hong ^a   Kim, Seung ^a   Kim, Myung Joon ^a   Kim, Hyun Gi ^a   Shin, Hyun Joo ^a   Lee, Mi Jung ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Child; Hepatic fat quantification magnetic resonance; Monitoring; Nonalcoholic fatty liver disease; Steatohepatitis

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA TOCOPHEROL; CHOLESTEROL; FAT; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; BIOLOGICAL MARKER;

ADOLESCENT; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BODY MASS; BODY WEIGHT; CHILD; CHILDHOOD DISEASE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HUMAN; LIPID ANALYSIS; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MALE; NONALCOHOLIC FATTY LIVER; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PATIENT MONITORING; RETROSPECTIVE STUDY; THERAPY EFFECT; TRIACYLGLYCEROL BLOOD LEVEL; ADIPOSE TISSUE; AGE; BLOOD; COMPARATIVE STUDY; EVALUATION STUDY; LIVER; MEDICAL RECORD; METABOLISM; NON-ALCOHOLIC FATTY LIVER DISEASE; PATHOLOGY; PATIENT COMPLIANCE; PREDICTIVE VALUE; TIME FACTOR; TREATMENT OUTCOME; YOUNG ADULT;

ADIPOSE TISSUE; ADOLESCENT; AGE FACTORS; BIOMARKERS; CHILD; FEMALE; HUMANS; LIVER; MAGNETIC RESONANCE IMAGING; MALE; MEDICAL RECORDS; NON-ALCOHOLIC FATTY LIVER DISEASE; PATIENT COMPLIANCE; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84941702428     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v21.i33.9741     Document Type: Article

References (31)

1. Lavine JE, Schwimmer JB, Van Natta ML, Molleston JP, Murray KF, Rosenthal P, Abrams SH, Scheimann AO, Sanyal AJ, Chalasani N, Tonascia J, Ünalp A, Clark JM, Brunt EM, Kleiner DE, Hoofnagle JH, Robuck PR. Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial. JAMA 2011; 305: 1659-1668 [PMID: 21521847 DOI: 10.1001/jama.2011.520]
2. Loomba R, Sirlin CB, Schwimmer JB, Lavine JE. Advances in pediatric nonalcoholic fatty liver disease. Hepatology 2009; 50: 1282-1293 [PMID: 19637286 DOI: 10.1002/hep.23119]
3. Schwimmer JB, Deutsch R, Kahen T, Lavine JE, Stanley C, Behling C. Prevalence of fatty liver in children and adolescents. Pediatrics 2006; 118: 1388-1393 [PMID: 17015527 DOI: 10.1542/peds.2006-1212]
4. Adams LA, Sanderson S, Lindor KD, Angulo P. The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies. J Hepatol 2005; 42: 132-138 [PMID: 15629518 DOI: 10.1016/j.jhep.2004.09.012]
5. Awai HI, Newton KP, Sirlin CB, Behling C, Schwimmer JB. Evidence and recommendations for imaging liver fat in children, based on systematic review. Clin Gastroenterol Hepatol 2014; 12: 765-773 [PMID: 24090729 DOI: 10.1016/j.cgh.2013.09.050]
6. Molleston JP, White F, Teckman J, Fitzgerald JF. Obese children with steatohepatitis can develop cirrhosis in childhood. Am J Gastroenterol 2002; 97: 2460-2462 [PMID: 12358273 DOI: 10.1111/j.1572-0241.2002.06003.x]
7. Pacana T, Sanyal AJ. Vitamin E and nonalcoholic fatty liver disease. Curr Opin Clin Nutr Metab Care 2012; 15: 641-648 [PMID: 23075940 DOI: 10.1097/MCO.0b013e328357f747]
8. Musso G, Cassader M, Rosina F, Gambino R. Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials. Diabetologia 2012; 55: 885-904 [PMID: 22278337 DOI: 10.1007/s00125-011-2446-4]
9. Kawanaka M, Nishino K, Nakamura J, Suehiro M, Goto D, Urata N, Oka T, Kawamoto H, Nakamura H, Yodoi J, Hino K, Yamada G. Treatment of nonalcoholic steatohepatitis with vitamins E and C: a pilot study. Hepat Med 2013; 5: 11-16 [PMID: 24695939 DOI: 10.2147/hmer.s41258]
10. Bell LN, Wang J, Muralidharan S, Chalasani S, Fullenkamp AM, Wilson LA, Sanyal AJ, Kowdley KV, Neuschwander-Tetri BA, Brunt EM, McCullough AJ, Bass NM, Diehl AM, Unalp-Arida A, Chalasani N. Relationship between adipose tissue insulin resistance and liver histology in nonalcoholic steatohepatitis: a pioglitazone versus vitamin E versus placebo for the treatment of nondiabetic patients with nonalcoholic steatohepatitis trial follow-up study. Hepatology 2012; 56: 1311-1318 [PMID: 22532269 DOI: 10.1002/hep.25805]
11. Castéra L, Nègre I, Samii K, Buffet C. Pain experienced during percutaneous liver biopsy. Hepatology 1999; 30: 1529-1530 [PMID: 10610352 DOI: 10.1002/hep.510300624]
12. Cadranel JF, Rufat P, Degos F. Practices of liver biopsy in France: results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF). Hepatology 2000; 32: 477-481 [PMID: 10960438 DOI: 10.1053/jhep.2000.16602]
13. Kim SY, Seok JY, Han SJ, Koh H. Assessment of liver fibrosis and cirrhosis by aspartate aminotransferase-to-platelet ratio index in children with biliary atresia. J Pediatr Gastroenterol Nutr 2010; 51: 198-202 [PMID: 20531020 DOI: 10.1097/MPG.0b013e3181da1d98]
14. Bravo AA, Sheth SG, Chopra S. Liver biopsy. N Engl J Med 2001; 344: 495-500 [PMID: 11172192 DOI: 10.1056/nejm200102153440706]
15. Bonny C, Rayssiguier R, Ughetto S, Aublet-Cuvelier B, Baranger J, Blanchet G, Delteil J, Hautefeuille P, Lapalus F, Montanier P, Bommelaer G, Abergel A. [Medical practices and expectations of general practitioners in relation to hepatitis C virus infection in the Auvergne region]. Gastroenterol Clin Biol 2003; 27: 1021-1025 [PMID: 14732848]
16. Shannon A, Alkhouri N, Carter-Kent C, Monti L, Devito R, Lopez R, Feldstein AE, Nobili V. Ultrasonographic quantitative estimation of hepatic steatosis in children With NAFLD. J Pediatr Gastroenterol Nutr 2011; 53: 190-195 [PMID: 21788761 DOI: 10.1097/MPG.0b013e31821b4b61]
17. Bohte AE, Koot BG, van der Baan-Slootweg OH, van Werven JR, Bipat S, Nederveen AJ, Jansen PL, Benninga MA, Stoker J. US cannot be used to predict the presence or severity of hepatic steatosis in severely obese adolescents. Radiology 2012; 262: 327-334 [PMID: 22106358 DOI: 10.1148/radiol.11111094]
18. Lee SW, Park SH, Kim KW, Choi EK, Shin YM, Kim PN, Lee KH, Yu ES, Hwang S, Lee SG. Unenhanced CT for assessment of macrovesicular hepatic steatosis in living liver donors: comparison of visual grading with liver attenuation index. Radiology 2007; 244: 479-485 [PMID: 17641368 DOI: 10.1148/radiol.2442061177]
19. Limanond P, Raman SS, Lassman C, Sayre J, Ghobrial RM, Busuttil RW, Saab S, Lu DS. Macrovesicular hepatic steatosis in living related liver donors: correlation between CT and histologic findings. Radiology 2004; 230: 276-280 [PMID: 14695401 DOI: 10.1148/radiol.2301021176]
20. Ma X, Holalkere NS, Kambadakone R A, Mino-Kenudson M, Hahn PF, Sahani DV. Imaging-based quantification of hepatic fat: methods and clinical applications. Radiographics 2009; 29: 1253-1277 [PMID: 19755595]
21. Pacifico L, Martino MD, Catalano C, Panebianco V, Bezzi M, Anania C, Chiesa C. T1-weighted dual-echo MRI for fat quantification in pediatric nonalcoholic fatty liver disease. World J Gastroenterol 2011; 17: 3012-3019 [PMID: 21799647 DOI: 10.3748/wjg.v17.i25.3012]
22. Pearlman M, Loomba R. State of the art: treatment of nonalcoholic steatohepatitis. Curr Opin Gastroenterol 2014; 30: 223-237 [PMID: 24717764 DOI: 10.1097/mog.0000000000000060]
23. Cassidy FH, Yokoo T, Aganovic L, Hanna RF, Bydder M, Middleton MS, Hamilton G, Chavez AD, Schwimmer JB, Sirlin CB. Fatty liver disease: MR imaging techniques for the detection and quantification of liver steatosis. Radiographics 2009; 29: 231-260 [PMID: 19168847]
24. Guiu B, Loffroy R, Petit JM, Aho S, Ben Salem D, Masson D, Hillon P, Cercueil JP, Krause D. Mapping of liver fat with tripleecho gradient echo imaging: validation against 3.0-T proton MR spectroscopy. Eur Radiol 2009; 19: 1786-1793 [PMID: 19247667 DOI: 10.1007/s00330-009-1330-9]
25. Lee SS, Park SH. Radiologic evaluation of nonalcoholic fatty liver disease. World J Gastroenterol 2014; 20: 7392-7402 [PMID: 24966609 DOI: 10.3748/wjg.v20.i23.7392]
26. Le TA, Chen J, Changchien C, Peterson MR, Kono Y, Patton H, Cohen BL, Brenner D, Sirlin C, Loomba R. Effect of colesevelam on liver fat quantified by magnetic resonance in nonalcoholic steatohepatitis: a randomized controlled trial. Hepatology 2012; 56: 922-932 [PMID: 22431131 DOI: 10.1002/hep.25731]
27. Westphalen AC, Qayyum A, Yeh BM, Merriman RB, Lee JA, Lamba A, Lu Y, Coakley FV. Liver fat: effect of hepatic iron deposition on evaluation with opposed-phase MR imaging. Radiology 2007; 242: 450-455 [PMID: 17255416 DOI: 10.1148/radiol.2422052024]
28. Qayyum A, Goh JS, Kakar S, Yeh BM, Merriman RB, Coakley FV. Accuracy of liver fat quantification at MR imaging: comparison of out-of-phase gradient-echo and fat-saturated fast spin-echo techniques-initial experience. Radiology 2005; 237: 507-511 [PMID: 16244259 DOI: 10.1148/radiol.2372040539]
29. Hwang I, Lee JM, Lee KB, Yoon JH, Kiefer B, Han JK, Choi BI. Hepatic steatosis in living liver donor candidates: preoperative assessment by using breath-hold triple-echo MR imaging and 1H MR spectroscopy. Radiology 2014; 271: 730-738 [PMID: 24533869 DOI: 10.1148/radiol.14130863]
30. Wu CH, Ho MC, Jeng YM, Hsu CY, Liang PC, Hu RH, Lai HS, Shih TT. Quantification of hepatic steatosis: a comparison of the accuracy among multiple magnetic resonance techniques. J Gastroenterol Hepatol 2014; 29: 807-813 [PMID: 24224538 DOI: 10.1111/jgh.12451]
31. Szczepaniak LS, Nurenberg P, Leonard D, Browning JD, Reingold JS, Grundy S, Hobbs HH, Dobbins RL. Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. Am J Physiol Endocrinol Metab 2005; 288: E462-E468 [PMID: 15339742 DOI: 10.1152/ajpendo.00064.2004]